Haw Par Corporation Limited (HAWPF)
OTCMKTS · Delayed Price · Currency is USD
12.45
+0.21 (1.76%)
At close: Jan 16, 2026
Haw Par Corporation Market Cap
Haw Par Corporation has a market cap or net worth of $3 billion as of February 12, 2026. Its market cap has increased by 58.69% in one year.
Market Cap
3.00B
Enterprise Value
2.47B
Revenue
198.72M
Ranking
n/a
PE Ratio
15.23
Stock Price
$12.45
Market Cap Chart
Since May 8, 1997, Haw Par Corporation's market cap has increased from 413.84M to 3.00B, an increase of 623.93%. That is a compound annual growth rate of 7.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 3.00B | 11.02% |
| Dec 31, 2025 | 2.70B | 49.21% |
| Dec 31, 2024 | 1.81B | 10.60% |
| Dec 29, 2023 | 1.64B | 3.39% |
| Dec 30, 2022 | 1.58B | -15.10% |
| Dec 31, 2021 | 1.86B | 4.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 766.76M |
| Glass House Brands | 710.47M |
| Elite Pharmaceuticals | 464.34M |
| Northwest Biotherapeutics | 411.40M |
| Nika Pharmaceuticals | 403.38M |
| American Oncology Network | 377.98M |
| OpGen | 340.99M |
| CytoDyn | 311.51M |